Journal Guide

Enzyme and Microbial Technology is an international, peer-reviewed journal publishing original research and reviews, of biotechnological significance and novelty, on basic and applied aspects of the science and technology of processes involving the use of enzymes, micro-organisms, animal cells and plant cells.We especially encourage submissions on:Biocatalysis and the use of Directed Evolution in Synthetic Biology and BiotechnologyBiotechnological Production of New Bioactive Molecules, Biomaterials, Biopharmaceuticals, and BiofuelsNew Imaging Techniques and Biosensors, especially as applicable to Healthcare and Systems BiologyNew Biotechnological Approaches in Genomics, Proteomics and MetabolomicsMetabolic Engineering, Biomolecular Engineering and NanobiotechnologyManuscripts which report isolation, purification, immobilization or utilization of organisms or enzymes which are already well-described in the literature are not suitable for publication in EMT, unless their primary purpose is to report significant new findings or approaches which are of broad biotechnological importance. Similarly, manuscripts which report optimization studies on well-established processes are inappropriate. EMT does not accept papers dealing with mathematical modeling unless they report significant, new experimental data.

Epigenetics is a multidisciplinary peer-reviewed journal that publishes original research and review articles covering the latest findings about epigenetic mechanisms and their role in diverse biological processes.Our goal is to establish Epigenetics as the lead journal in the field by providing a forum where epigenetic approaches to a variety of medical and biological issues can be discussed and the common basic principles of epigenetics spanning different systems can be revealed and shared.The field of epigenetics studies the changes in gene expression that are caused by mechanisms other than the modification of the DNA sequence. Epigenetics covers many different levels of biological control and relates to diverse biological systems, diseases and disciplines. Although in recent years cancer has been the main focus of epigenetic studies, recent data suggests that epigenetics also plays critical roles in psychology and psychopathology. It is being realized that normal behaviors, such as maternal care, and pathologies, such as Schizophrenia and Alzheimer disease, might have an epigenetic basis. It is also becoming clear that nutrition and life experiences have consequences that are mediated by epigenetic mechanisms. The increasing awareness of the potential role of epigenetic deregulation in disease has spawned the development of diagnostic and therapeutic approaches using epigenetics. Although the questions asked are diverse, the unifying hypothesis is that epigenetics is involved. The journal provides a platform for developing unifying methodologies, hypotheses, experimental approaches and diagnostic agents and serves as a meeting place for researchers working in different systems such as general biology, plant biology, cancer biology, cancer therapeutics, epigenetic pharmacology, neurobiology and psychiatry, who are unraveling the epigenetic facets of their specific fields of interest.

Epigenetics & Chromatin welcomes all high-quality articles that provide novel insights into epigenetic inheritance and chromatin-based interactions. Topics include, but are not limited to, gene silencing and imprinting, cellular reprogramming, nucleosome modification assembly and remodeling, DNA methylation, chromatin structure and dynamics, chromosomal maintenance elements, dosage compensation, interchromosomal interactions and prion inheritance.

Epigenomics promises to elucidate the inner workings of the genome. The power of this new discipline lies in its promise to provide us with novel insights into the inner workings of our genomes through its potential to detect quantitative changes, multiple modifications and the regulatory sequences outside that of our gene sequences. The advent of numerous epigenomics strategies has emerged to detect large numbers of DNA methylation variations and chromatin modifications – two mechanisms that are at the core of epigenomic research. Epigenomics provides the forum to address the rapidly progressing research developments in this ever-expanding field; to report on the major challenges ahead and critical advances that are propelling the science forward. The journal delivers this information in concise, at-a-glance article formats – invaluable to a time-constrained community.

Essays in Biochemistry publishes short, digestible reviews from experts highlighting recent key topics in biochemistry and the molecular biosciences. Written to be accessible for those not yet immersed in the subject, each article is an up-to-date, self-contained summary of the topic.
Bridging the gap between the latest research and established textbooks, Essays in Biochemistry will tell you what you need to know to begin exploring the field, as each article includes the top take-home messages as summary points.

EuPA Open Proteomics is published by Elsevier on behalf of the European Proteomics Association (EuPA) and is aimed at both European and international protein scientists.Expanding and complementing the society affiliate Journal of Proteomics, EuPA Open Proteomics will publish on all aspects of proteomics and cover the complete spectrum from basic to translational proteomics. Particularly welcome are reports on novel methodological and technical developments, including bioinformatics and data processing, mass spectrometry imaging, pathway analysis, peptidomics, lipidomics and glycomics. It will also accept direct submissions from authors wishing to report on large data sets (submitted to raw data repositories) and descriptive studies. Manuscripts are welcome from plant, animal, microbial and human studies. All manuscripts are strictly peer reviewed and conform the highest ethical standards. EuPA Open Proteomics also publishes official EuPA reports and notes.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Euphytica is an international journal covering the theoretical and applied aspects of plant breeding, and publishing critical reviews and papers on original research.The journal reports on the growing field of research associated with the integration of modern and traditional plant breeding using transgenic crop plants and/or marker assisted breeding in combination with traditional breeding tools. The content addresses the interests of researchers involved in plant breeding at universities, breeding institutes, seed industries, plant biotech companies and industries using plant raw materials, and promoting stability, adaptability and sustainability in agriculture and agro-industries. The Editor-in-Chief of Euphytica is R.G.F. Visser, Laboratory of Plant Breeding, Wageningen University, The Netherlands.

The European Biophysics Journal publishes papers in the field of biophysics, defining biophysics as the study of biological phenomena using physical methods and concepts. The journal presents original papers, reviews and letters. The primary goal of this journal is to advance the understanding of biological structure and function by application of the principles of physical science, and by presenting the work in a biophysical context. Principal areas of interest include: structure and dynamics of biological macromolecules; membrane biophysics and ion channels; cell biophysics and organisation; macromolecular assemblies; biophysical methods and instrumentation; advanced microscopics; and system dynamics. The journal is published on behalf of the European Biophysical Societies Association.

eCM provides an interdisciplinary forum for publication of preclinical research in the musculoskeletal field (Trauma, Maxillofacial, Spine and Orthopaedics) and the cells and materials used in the replacement, repair or regeneration of these tissues.The clinical relevance of the work must be briefly mentioned within the abstract, and in more detail in the discussion.Poor abstracts which do not concisely cover the paper contents will not be sent for review. Incremental steps in research will not be entertained by eCM journal.Please CAREFULLY read the Instructions to Authors before submission to save early disappointment. It is highly recommended that a well prepared abstract is sent to the Editor-in-Chief before submission to see if the area or results would fit eCM journal.

Excellence in medical and scientific information.A leader in the field of medical publishing for the past 20 years, John Libbey Eurotext has compiled a prestigious catalogue of books and publishes more than 60 new titles every year. A wide variety of series: scientific meeting reports, monographs and practical guides both aimed at general practioners and specialists.

The journal European Food Research and Technology publishes state-of-the-art research papers and review articles on fundamental and applied food research. The journal's mission is the fast publication of high quality papers on front-line research, new and novel techniques and developing trends in such disciplines as chemistry and biochemistry; technology and molecular biotechnology; nutritional chemistry and toxicology; analytical and sensory methodologies and food physics. The Editors-in-Chief are T. Henle, Technische Universität Dresden, and T. Hofmann, Technische Universitat Munchen, Germany.

With a focus on human integrative and translational physiology, the European Journal of Applied Physiology publishes original research that is considered likely to further our understanding of the functioning of the intact healthy human body under a variety of environmental (e.g. altitude, climatic, gravitational) and exercise conditions. Contexts include those relating to occupational, sporting, recreational and daily activities throughout the human life-span from childhood to old age.

The European Journal of Cancer (EJC) is an international multidisciplinary oncology journal, which publishes original research, reviews, and editorial comments on basic and preclinical cancer research, translational oncology, clinical oncology - including medical oncology, paediatric oncology, radiation oncology, and surgical oncology, and cancer epidemiology and prevention.The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO), the European Association for Cancer Research (EACR) and the European Society of Breast Cancer Specialists (EUSOMA).Why publish your work in the EJC?Efficient peer-review: The EJC's Editors and reviewers are committed to maintaining the high standards of the journal. All manuscripts submitted to the EJC will be evaluated by the journal's Editors. Some manuscripts may be rejected outright following this evaluation, allowing the authors to submit their work elsewhere. Those manuscripts which are judged as being eligible for consideration by the Editors will be subject to peer-review. The full peer-review policy for the EJC can be found here.The EJC has an online submission and peer-review system to facilitate the submission and peer-review of submitted manuscripts. Authors are able to upload their manuscript quickly and track the status of their manuscript throughout the review process.Online Publication as an Article-in-Press: All manuscripts that are accepted for publication in the EJC are published online as Articles-in-Press within 4 - 5 weeks of acceptance. Articles-in-Press can be cited using the unique digital object identifier (DOI) which is assigned to all papers. In addition, Articles-in-Press are indexed in PubMed.The EJC's readership: The EJC is published in print and online and is available to more than 17,000 academic and clinical institutions, personal subscribers and members of the journal's Society Partners (the EORTC, ECCO, EACR and EUSOMA). In 2011 the journal had more than 83,000 articles downloaded per month from across the world.The EJC has an iPad app, making each issue of the journal available to our readers in this format. Visit http://itunes.apple.com/us/app/ejc-app/id461022524?mt=8 to find out more.eTables of Contents: Our readers can elect to receive free eTables of Contents via email, which are sent out for each issue of the journal.Abstracting and Indexing Coverage: The EJC is included in the leading abstracting and indexing services, including PubMed/MEDLINE, Current Contents/Clinical Medicine, the Science Citation Index, the Journal Citation Reports and Scopus.HINARI: The EJC is part of HINARI (Health InterNetwork Access to Research Initiative) administered by the World Health Organisation. The HINARI Programme enables developing countries to gain access to one of the world's largest collections of biomedical and health literature.Why read the EJC?High quality original research and review articles: The EJC is a multidisciplinary journal, publishing high quality original research and review articles on basic and preclinical research, translational oncology, clinical oncology (medical, paediatric, radiation, surgical), and cancer epidemiology and prevention from across the world.Guidelines: The EJC is privileged to publish selected treatment guidelines from the journal's Society Partners (the EORTC, ECCO, EACR and EUSOMA) and other groups.Special Series: The EJC publishes special series of papers on linked topics of particular relevance and interest to the journal's readers.EJC News and EJC News Focus: Each month, the journal publishes the EJC News, discussing and commenting on current issues in cancer, together with the EJC News Focus, a series of video interviews with key opinion leaders in oncology.

The European Journal of Cancer Prevention emphasizes the rapid publication of important research into fundamental aspects of cancer prevention, making it essential reading for researchers in a wide variety of fields. The scope is wide ranging, including descriptive and metabolic epidemiology, histopathology, lifestyle issues, environment, genetics, biochemistry, molecular biology, microbiology, clinical medicine, intervention trials and public education, basic laboratory studies and special group studies.Website: www.eurjcancerprev.com.

EJC Supplements is an open access companion journal to the European Journal of Cancer. As an open access journal, all published articles are subject to an Article Publication Fee. Immediately upon publication, all articles in EJC Supplements are made openly available through the journal's websites.EJC Supplements will consider for publication the proceedings of scientific symposia, commissioned thematic issues, and collections of invited articles on preclinical and basic cancer research, translational oncology, clinical oncology and cancer epidemiology and prevention.Authors considering the publication of a supplement in EJC Supplements are requested to contact the Editorial Office of the EJC to discuss their proposal with the Editor-in-Chief.EJC Supplements is an official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European Association for Cancer Research (EACR), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA).

The European Journal of Cell Biology, a journal of experimental cell investigation, publishes reviews, original articles and short communications on the structure, function and macromolecular organization of cells and cell components. Contributions focusing on cellular dynamics, motility and differentiation, particularly if related to cellular biochemistry, molecular biology, immunology, neurobiology, and developmental biology are encouraged. Manuscripts describing significant technical advances are also welcome. In addition, papers dealing with biomedical issues of general interest to cell biologists will be published. Contributions addressing cell biological problems in prokaryotes and plants are also welcome.

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

The European Journal of Human Genetics is the official journal of the European Society of Human Genetics, publishing high-quality, original research papers, short reports and reviews in the rapidly expanding field of human genetics and genomics. It covers molecular, clinical and cytogenetics, interfacing between advanced biomedical research and the clinician, and bridging the great diversity of facilities, resources and viewpoints in the genetics community.Key areas include: * Monogenic and multifactorial disorders * Development and malformation * Hereditary cancer * Medical Genomics * Gene mapping and functional studies * Genotype-phenotype correlations * Genetic variation and genome diversity * Statistical and computational genetics * Bioinformatics * Advances in diagnostics * Therapy and prevention * Animal models * Genetic services * Community geneticsThe journal also publishes invited editorials and commentaries, announcements of societal and other European activities and special issues of general interest for the human genetics community.